What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Pharma Industry News Does Priority Review signal a commercial breakthrough for Protagonist Therapeutics, Inc.? Takeda and Protagonist secure FDA Priority Review for rusfertide in PV. Explore the strategic, financial, and competitive implications now. bySoujanya RaviMarch 5, 2026